• Introduction
  • All Faculty
  • Full Time & Joint Faculty
  • Professors Emeritus
  • Associate Faculty
  • Part Time Faculty
• Gallery of Distinguished Faculty
• Accolades & Awards
• Connect to Research Expertise
• Faculty Reflections

Clinical Epidemiology & Biostatistics

Daria O'Reilly

Academic Interests

Daria O’Reilly is a new faculty member in the Department of Clinical Epidemiology and Biostatistics. She holds a faculty position as an Assistant Professor and is also the Faculty Director of the Field Evaluation and Economic Assessment Program (FEEAP) within the Programs for Assessment of Technology in Health (PATH) Research Institute.

In her academic capacity, Daria has established a course entitled Introduction to Health Technology Assessment within the Health Research Methodology Program (HRM 741).  She is currently the coordinator and an instructor in the newly developed course.

Since arriving at McMaster as a post-doctoral fellow in 2003, Daria’s program of research has focused on the development and application of a diabetes economic model for tracking the impact of the management of type 2 diabetes in Ontario.  The model simulates the long-term costs and health outcomes of new and existing type 2 diabetes management strategies in order to help inform decision-making in policy, planning and the delivery of diabetes care in Ontario.  Using this model, Daria has evaluated a number of diabetes management interventions on behalf of the Ontario Health Technology Advisory Committee (OHTAC).

For her work in the area of diabetes, Daria has been awarded the 2007 Provincial Career Scientist Award under the Health Research Personnel Development (HRPD) Program within the Ontario Ministry of Health and Long-Term Care.

Daria’s research areas include economic evaluation, health technology assessment, health policy, systematic review, meta-analysis, pharmacoepidemiology and clinical epidemiology.  She is currently involved in the economic evaluation of various health technology assessments including, insulin pumps for type 1 diabetes, the use of an electronic chronic disease management system in primary care, hyperbaric oxygen therapy for chronic ulcers of the lower limb, a complex care coordination program designed to reduce obesity in children, and medication management through health information technology, to name a few.

Selected Publications

1. O’Reilly DJ, Goeree R, Tarride JE, Janes C, Parfrey P.  The Unintended (and Costly) Effects due to the Introduction of an Unrestricted Reimbursement Policy for Atypical Antipsychotic Medications in a Canadian Public Prescription Drug Program: 1996/97to 2005/06.  Can J Clin Pharmacol Vol 16 (2) Summer 2009:e346-e359; June 16, 2009.
2. O'Reilly D, Campbell K, Goeree R; Basics of health technology assessment.  Programs for Assessment of Technology in Health Research Institute.  Methods Mol Biol. 2009;473:263-83.
3. Goeree R, Lim ME, Hopkins R, Blackhouse G, Tarride J-E, Xie F, O’Reilly D.  Prevalence, total and excess costs of diabetes and related complications in Ontario, Canada.  Canadian Journal of Diabetes 2009;33(1):35-45.
4. Lim M, O’Reilly D, Tarride JE, Burke N, Ferrusi I, Goeree R.  Health technology assessment for radiologists: basic principles and evaluation framework.  Journal of the American College of Radiology 2009;6(5):299-306.
5. Bowen JM, Patterson LL, O’Reilly D, Hopkins RB, Blackhouse G, Burke N, Xie F, Tarride JE, Goeree R.  Conditionally funded field evaluations and practice trial design within a HTA framework.  Journal of the American College of Radiology 2009;6(5):324-31.
6. Goeree R, Levin L, Chandra K, Bowen JM, Blackhouse G, Tarride JE, Burke N, Bischof M, Xie F, O’Reilly D.  Health technology assessment and primary data collection for reducing decision making uncertainty.  Journal of the American College of Radiology 2009;6(5):332-42.
7. Goeree R, Lim ME, Hopkins R, Blackhouse G, Tarride J-E, Xie F, O’Reilly D.  Excess risk of mortality and complications associated with newly diagnosed cases of diabetes in Ontario, Canada.  Canadian Journal of Diabetes 2009:33(2):93-104.
8. Lim ME, Bowen JM, O’Reilly D, McCarron CE, Blackhouse G, Hopkins R, Goeree R, Tarride JE.  Impact of the 1997 Canadian guidelines on the conduct of Canadian-based economic evaluations in the published literature.  Value in Health 2009:Sep 25.
9. Blackhouse G, Hopkins R, Bowen JM, DeRose G, Novick T, Tarride J-E, O’Reilly D, Xie F, Goeree R.  A cost-effectiveness model comparing endovascular repair to open surgical repair of abdominal aortic aneurysms in Canada.  Value in Health 2009;12(2):245-52.
10. Tarride JE, McCarron CE, Lim M, Bowen J, Blackhouse R, Hopkins R, O’Reilly D, Xie F, Goeree R.  Economic evaluations conducted by Canadian Health Technology Assessment agencies.  Where do we stand?  International Journal of Technology Assessment in Health Care 2008 Fall;24(4):437-44.

Search for citations for Dr. O'Reilly on PubMed